News
Dr. Cristóbal Orellana, Associate Physician at the Service of Rheumatology of the Parc Taulí Hospital (Sabadell, Barcelona) commented that biomarkers extracted from type II collagen, a type of collagen that can be found only in the cartilage, holds great promise for diagnosing osteoarthritis, and for monitoring its treatment.
Genetics, key to predict the progression of osteoarthritis
A clinical trial by Prof. Jean-Pierre Pelletier has been published in Annals of the Rheumatic Diseases this week
Immunactive is a nutritional supplement containing an exclusive formulation of nucleotides that helps stimulate the body's own defenses.
In 2009, Immunactive was launched on the Spanish market, where it has earned itself a highly favourable reception. The next step is to enter the international market.
- On 23 September, Brussels held the World Congress on Osteoarthritis, hosted by the OARSI. Bioiberica was there to present the results of a range of studies conducted over the past year. In addition, we hosted two symposia on osteoarthritis: